HUYA Bioscience International, focused on accelerating the global development of China’s pharmaceutical innovations, has formed a strategic partnership with Tianjin Research Center of Basic Medical Sciences (TJRCBMS), a nonprofit Chinese research institution.
The new partnership between HUYA and TJRCBMS will enable both parties to collaborate to promote new drug development in China and worldwide, with a focus on innovations that could meet critical global pharmaceutical pipeline needs. TJRCBMS will be able to consult with HUYA's team of experts in drug development and globalization. In turn, HUYA will have the first opportunity to evaluate certain research and development projects conducted at TJRCBMS, and provide support and assistance as needed.
TJRCBMS is located on the Tianjin Medical University campus and was founded by the municipal government of Tianjin in 2005. Its mission is to be on the global biomedical research frontiers and serve China's strategic development needs.